Critical Review: SeaStar Medical (NASDAQ:ICU) vs. Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)

SeaStar Medical (NASDAQ:ICU) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

Valuation & Earnings

This table compares SeaStar Medical and Senseonics Holdings, Inc. Common Stock”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.44 million	9.76	-$12.15 million	($3.91)	-0.81
Senseonics Holdings, Inc. Common Stock	$35.26 million	9.26	-$69.11 million	($2.23)	-3.50

SeaStar Medical has higher earnings, but lower revenue than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

SeaStar Medical has a beta of -1.05, meaning that its share price is 205% less volatile than the S&P 500. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for SeaStar Medical and Senseonics Holdings, Inc. Common Stock, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1	0	1	0	2.00
Senseonics Holdings, Inc. Common Stock	1	1	4	0	2.50

SeaStar Medical presently has a consensus price target of $8.00, indicating a potential upside of 151.57%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 120.23%. Given SeaStar Medical’s higher probable upside, research analysts clearly believe SeaStar Medical is more favorable than Senseonics Holdings, Inc. Common Stock.

Profitability

This table compares SeaStar Medical and Senseonics Holdings, Inc. Common Stock’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%

Institutional and Insider Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Senseonics Holdings, Inc. Common Stock beats SeaStar Medical on 9 of the 14 factors compared between the two stocks.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.